Merck (MRK) Shares Issued (2009 - 2026)
Merck (MRK) reported Shares Issued of $157.0 million for Q1 2026, up 726.32% year-over-year from $19.0 million in Q1 2025, and up 234.04% quarter-over-quarter from $47.0 million in Q4 2025.
Merck (MRK) Shares Issued (2009 - 2026) Analysis & Trends
Merck (MRK) has 18 years of Shares Issued data on file, last reported at $157.0 million in Q1 2026.
- Shares Issued for Q1 2026 came in at $157.0 million, up 726.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $230.0 million (up 111.01% YoY), and the FY2025 annual result was $92.0 million, down 48.02% from the prior year.
- Shares Issued improved to $157.0 million in Q1 2026 per MRK's latest filing, from $47.0 million in the prior quarter.
- Over five years, Shares Issued peaked at $265.0 million in Q4 2022 and troughed at $5.0 million in Q3 2024.
- A 5-year average of $55.0 million and a median of $19.0 million in 2025 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2026: Shares Issued tumbled 97.74% in 2023, then jumped 726.32% in 2026.
- A 5-year view of Shares Issued shows it stood at $265.0 million in 2022, then plunged by 97.74% to $6.0 million in 2023, then jumped by 100.0% to $12.0 million in 2024, then soared by 291.67% to $47.0 million in 2025, then jumped by 234.04% to $157.0 million in 2026.
- Business Quant data shows MRK's Shares Issued at $157.0 million in Q1 2026, $47.0 million in Q4 2025, and $14.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 157.00 Mn |
| Mar 31, 2026 | 157.00 Mn |
| Dec 31, 2025 | 47.00 Mn |
| Dec 31, 2025 | 47.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Jun 30, 2025 | 12.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 73.00 Mn |
| Jun 30, 2024 | 73.00 Mn |
| Mar 31, 2024 | 87.00 Mn |
| Mar 31, 2024 | 87.00 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Dec 31, 2023 | 6.00 Mn |